April 29, 2020 / 12:44 PM / a month ago

BRIEF-Heat Biologics Announces Strategy & Anticipated Q2 Milestones For Covid-19 Vaccine Program

April 29 (Reuters) - Heat Biologics Inc:

* HEAT BIOLOGICS - ANNOUNCED STRATEGY & ANTICIPATED Q2 2020 MILESTONES FOR COVID-19 VACCINE PROGRAM

* HEAT BIOLOGICS - ANTICIPATED Q2 MILESTONES INCLUDE COMPLETION OF DEVT OF A CELL-BASED VACCINE EXPRESSING GP96-IG, OX40L-IG, SARS-COV-2 PROTEIN S

* HEAT BIOLOGICS - ANTICIPATED Q2 MILESTONES INCLUDE SUBMISSION OF GRANT APPLICATIONS TO FUND AND ACCELERATE COVID-19 VACCINE DEVELOPMENT

* HEAT BIOLOGICS - COMMENCEMENT OF PRECLINICAL TESTING OF COVID-19 VACCINE PLANNED TO COMMENCE THIS QUARTER, WILL REPORT PRELIM DATA SHORTLY THEREAFTER Source: (bit.ly/2YfvFmQ) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below